|
|
|
|
|
by alexqgb
3394 days ago
|
|
Part of the reason those drugs exist in the first place is that they've been engineered to extract the maximum amount of cash possible from our nightmare of a system. Yes, you may blow through your lifetime cap on one ailment, but the incentives are in place for pharma makers to see that as much of your cap ends up in their pockets, rather than the competitions. Treatments for Hepatitis-C are one of the more notorious examples of drugs being developed to maximally exploit our system. The point of controlling costs is to provide incentives for developing drugs that not only work, but that do so at non-ruinous prices. |
|
And also, the cost of those HCV therapies is actually cheaper in the US than in the EU.[1]
[1]https://www.forbes.com/sites/johnlamattina/2015/12/04/for-he...